Tuesday, June 08, 2010

OgilvyHealthPR wins Boehringer Ingelheim anti-clot drug brief

OgilvyHealthPR wins Boehringer Ingelheim anti-clot drug brief

Pharma firm Boehringer Ingelheim has brought in OgilvyHealthPR as the global comms agency for its Pradaxa drug, which prevents blood clotting.
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)